AMLN up on exenatide diabetes data

By BC Staff | Aug 7, 2003 | 7:00 AM GMT

Amylin (AMLN) was up $1.46 to $22.71 on 5.8

Read the full 91 word article

How to gain access

Continue reading with a
two-week free trial.